Next Article in Journal
Assessment of Leaching Characteristics of Solidified Products Containing Secondary Alkaline Lead Slag
Previous Article in Journal
Characterization of Biofilm Formed by Phenanthrene-Degrading Bacteria on Rice Root Surfaces for Reduction of PAH Contamination in Rice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 16
Issue 11
10.3390/ijerph16112004
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Utility and Predictive Value of Human Standard Semen Parameters and Sperm DNA Dispersion for Fertility Potential

by
Kamil Gill
1,
Joanna Jakubik
1,
Aleksandra Rosiak-Gill
1,2,
Michał Kups
1,2,3,
Mariusz Lukaszuk
4,5,
Maciej Kurpisz
6,
Monika Fraczek
6 and
Małgorzata Piasecka
1,*
1
Department of Histology and Developmental Biology, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland
2
VitroLive Fertility Clinic in Szczecin, 70-483 Szczecin, Poland
3
Department of Urology and Oncological Urology, Regional Specialist Hospital in Szczecin, 71-455 Szczecin, Poland
4
Healthcare Center Nowe Orlowo, 81-525 Gdynia, Poland
5
Invicta Fertility Clinic, 80-850 Gdansk, Poland
6
Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2019, 16(11), 2004; https://doi.org/10.3390/ijerph16112004
Submission received: 13 May 2019 / Revised: 29 May 2019 / Accepted: 3 June 2019 / Published: 5 June 2019
(This article belongs to the Section Health Behavior, Chronic Disease and Health Promotion)
Browse Figures
Versions Notes

Abstract

:
Because the assessment of sperm DNA fragmentation (SDF) plays a key role in male fertility, our study was designed to find the relationships between SDF and standard semen parameters. The receiver operating characteristic (ROC) curve showed that 18% SDF is a prognostic parameter for discriminating between men with normal and abnormal standard semen parameters (n = 667). Men with > 18% SDF had significantly lower quality semen, a higher prevalence of abnormal semen characteristics, and a higher odds ratio for abnormal semen parameters compared to men with ≤ 18% SDF. An ROC analysis provided predictive values for age and semen parameters to distinguish between men with SDF > 18% and men with ≤ 18% SDF. SDF was positively correlated with male age and teratozoospermia index but negatively with sperm concentration, total number of spermatozoa, sperm morphology, progressive motility, and vitality. Our study shows that 18% SDF has a predictive value for distinguishing between men with normal and abnormal semen characteristics. Men with >18% SDF have a higher risk for abnormal semen parameters, while age and obtained semen parameters have a predictive value for SDF. There is a relationship between SDF and conventional sperm characteristics, and thus, SDF can be incorporated into male fertility assessment.

1. Introduction

Approximately up to 20% of couples trying to achieve pregnancy suffer from infertility [1,2,3]. It is known that male factors are responsible for 20–70% of cases, and one-third of these cases may be caused by male factors alone [1,2,3,4,5]. Male factors can influence not only the fertilization process but also embryo gene expression and development. In addition, male factors may also be involved in idiopathic miscarriages, as well as autosomal dominant diseases and neurobehavioural disorders in offspring, especially in cases of advanced paternal age [6,7,8,9,10]. Commonly, the assessment of male fertility potential is based on standard semen analysis. However, evidence from recent years has shown that basic seminological analysis may not always be an optimal diagnostic tool, but it still remains the basic clinical tool for evaluation male fertility potential [11,12]. On the other hand, some reports have even indicated the limited clinical utility of this analysis and demonstrated that searching for the best biomarker for the diagnosis of male infertility is required [13,14,15,16,17,18].
Many authors have shown that knowledge about the level of DNA damage is essential and provides the possibility of an optimal approach to an infertility problem [13,18,19,20,21]. Sperm DNA fragmentation is a male infertility factor associated with failure to conceive, longer times to pregnancy, poor outcome of infertility treatment (including in vitro fertilization), impaired embryo development, higher miscarriage rates, and health problems in offspring [13,15,21,22,23]. It should be highlighted that clinical data show that when the SDF is above 20%, the chance of natural pregnancy may be reduced, and that when SDF is above 30%, the chance for achieving pregnancy in natural conception or by insemination is very low [11,12,24,25,26,27,28]. For this reason, an analysis of SDF is recommended, particularly in difficult clinical cases, such as varicocele (often before varicocelectomy), idiopathic male infertility, miscarriages, unsuccessful ART treatment, influence of an unhealthy lifestyle, and advanced paternal age [13,19,20]. Therefore, the aims of our study were to 1) estimate the threshold of SDF distinguishing males with abnormal standard semen parameters (decreased fertility potential) and normal standard semen parameters, and 2) perform a mutual analysis of associations between sperm DNA fragmentation, age and standard semen parameters.

2. Subjects

The study was performed on ejaculated sperm cells obtained from a general population of men (n = 667, median of age = 32 years) attending the Andrology Laboratory of Department of Histology and Developmental Biology (Pomeranian Medical University in Szczecin, Poland). The laboratory is a research and scientific unit and access to research was open and unlimited—any adult man could take part in the research. The groups of men with normal standard semen parameters (n = 234) and with abnormal standard semen parameters (n = 434) were created according to the World Health Organization (WHO) [29] criteria. In both groups, the exclusion criteria included the following: a clinical picture suggestive of obstructive azoospermia, a history of testicular torsion, maldescent, injury or cancer, co-existing systemic disease, and a history of mumps. The ethics committee of the Pomeranian Medical University, Szczecin, Poland approved the study protocol (ethical authorization number: KB-0012/21/18).
The semen samples were collected after 2–7 days of sexual abstinence by masturbation. Sperm concentration was calculated in an improved Neubauer haemocytometer (Heinz Hernez Medizinalbedarf GmbH, Hamburg, Germany). In turn, sperm motility (total and progressive motility), vitality (live sperm cells: eosin-negative or hypo-osmotic-reactive sperm cells (HOS) test) were examined with phase-contrast microscope (Primo Star, Zeiss, Germany), but sperm morphology with a bright light microscope (CX 31 Olympus Optical Co., Ltd., Tokyo, Japan), respectively. Papanicolaou-stained spermatozoa were used for sperm morphology and teratozoospermia index (TZI) assessment. The concentration of leukocytes in the semen samples (peroxidase-positive cells) was calculated using the Endtz test (LeucoScreen kit, FertiPro N.V., Beernem, Belgium).
Normozoospermia (n = 242) was considered according to the following WHO [29] criteria: sperm concentration ≥15 mln/mL, total number of sperm cells ≥39 mln, sperm progressive motility ≥32% and morphology ≥4%. Furthermore, the TZI, vitality, and concentration of peroxidase-positive cells (leukocytes) were evaluated. In the group of men with abnormal standard semen parameters (n = 434), the following seminological categories were noted: asthenozoospermia (men with abnormal sperm motility, n = 7); oligozoospermia (men with abnormal number of sperm cells, n = 19); teratozoospermia (men with abnormal sperm morphology n = 162); asthenoteratozoospermia (men with abnormal sperm motility and morphology, n = 56); oligoasthenospemia (men with abnormal number and motility of sperm cells, n = 2); oligoteratozoospermia (men with abnormal number and morphology of sperm cells, n = 81); and oligoasthenoteratozoospermia (men with abnormal number, motility and morphology of sperm cells, n = 107).

2.1. Sperm Chromatin Dispersion (SCD) Test (Halosperm Test)

The SCD test was used to verify SDF. The evaluation of DNA dispersion after denaturation was carried out using a Halosperm G2 kit (Halotech DNA, Madrid, Spain) following the manufacturer’s guidelines: (1) preparation of a mixture containing sperm cells (≤ 20 mln/mL) and melted agarose (1:2); (2) placement of the sperm suspension (10 µL) on the centre of a super-coated slide; and (3) denaturation, lysis, dehydration, and staining of sperm cells with eosin and thiazine.
The smears were evaluated under a bright light microscope at x1000 magnification (CX 31 Olympus Optical Co., Ltd., Tokyo, Japan). A minimum of 300 spermatozoa per sample were counted. Sperm cells without SDF can produce the characteristic halo of dispersed DNA loops (large halo: halo width similar to or higher than the diameter of the sperm head; medium halo: halo width > 1/3 the diameter of the sperm head), while spermatozoa with damaged DNA fail to form a halo of dispersed DNA loops (small halo: halo width ≤ 1/3 the diameter of the sperm head; sperm cells without a halo or degraded: spermatozoa with no halo or irregular, weakly stained sperm head). The results are presented as the total number of spermatozoa with small or no halo, that is, degraded, divided by the total number of assessed sperm cells, and multiplied by 100% [30,31].

2.2. Statistical Analyses

The statistical analyses were performed using the software Statistica version 13.3 (StatSoft, Cracow, Poland) and MedCalc version 15.2.2 (MedCalc Software, Ostend, Belgium), with significance set at p < 0.05. The quantitative variables are expressed as the mean ± standard deviation (SD) and median (range), while categorical data are reported as percentages. The conformity of numerical variables with the normal distribution was examined using the Shapiro–Wilk test. Therefore, the nonparametric Mann–Whitney U test was used to compare data from two independent groups. A chi-square test was performed to compare the categorical data. The interdependences of the variables were examined by calculating the rank Spearman correlation coefficient (rs). To interpret the strength dependence between the study parameters, the following levels of correlation were presumed: <0.2—lack of linear dependence, 0.2–0.4—weak dependence, >0.4–0.7—moderate dependence, >0.7–0.9—strong dependence, >0.9—very strong dependence. The predictive values of obtained parameters were verified using the receiver operating characteristic (ROC) curve and the area under curve (AUC), taking into account the standard error (SE) and 95% confidence interval (CI 95%). The following levels of AUC were: 0.9–1.0—excellent predictive value, >0.8–0.9—good predictive value, >0.7–0.8—satisfactory predictive value, >0.6–0.7—moderate predictive value, 0.5–0.6—insufficient predictive value. The odds ratios (OR) for SDF levels (their 95% confidence intervals and p value) to define the relative risk in predicting the abnormal standard semen parameters in study group with respect to the SDF level were calculated.

3. Results

The first performed ROC analysis provided suggested an optimal satisfactory threshold of 18% SDF (AUC = 0.753) to distinguish between men with abnormal and normal standard semen parameters (Figure 1 and Figure 2). Based on this ROC analysis, study groups were divided into two groups: men with > 18% SDF (n = 334) and men with ≤ 18% SDF (n = 343). A comparison of the groups showed statistically significant differences (p < 0.05) in evaluated parameters except for semen volume (Table 1). Men with >18% SDF were significantly older (median: 33.00 y vs. 31.00 y) and had a lower sperm concentration (median: 14.60 mln/mL vs. 25.70 mln/mL), lower total number of sperm cells (median: 53.32 mln vs. 75.62 mln), lower number of spermatozoa with normal morphology (median: 1.00% vs. 4.00%), lower number of sperm cells with progressive motility (median: 39.00% vs. 61.00%), fewer eosin-negative (live) spermatozoa (median: 70.50% vs. 81.00%), and fewer HOS test-positive (live) spermatozoa (median: 70.00% vs. 80.00%). In addition, they had significantly higher TZI (median: 1.63 vs. 1.50) and a higher concentration of peroxidase-positive cells (median: 0.25 mln/mL vs. 0.12 mln/mL) compared to men with ≤ 18% SDF.
Moreover, men with > 18% SDF presented a significantly higher prevalence of abnormal standard semen parameters than men with SDF ≤ 18% (incidence of abnormal standard semen parameters: 82.34% vs. 46.36%, respectively) (Table 2). Additionally, men with > 18% SDF had a significantly higher OR for having abnormal standard semen parameters (OR: 5.394) than men with ≤ 18% SDF (Table 3).
The second ROC analysis provided information about the predictive value of age and standard semen analysis for sperm DNA fragmentation (Figure 2). The calculated threshold value of age (32 y), sperm concentration (13.80 mln/mL), total number of sperm cells (27.75 mln), sperm morphology (2.00%), TZI (1.52), progressive motility (50.00%), eosin-negative sperm cells (74.00%) and HOS test-positive sperm cells (71.00%) had predictive value for distinguishing between men with > 18% SDF and men with ≤ 18% SDF (Table 4); however, semen volume and concentration of peroxidase-positive cells had no predictive value.
An evaluation of the rank Spearman correlation revealed that SDF was positively correlated with male age (rs = 0.211) and TZI (rs = 0.339), but was negatively correlated with sperm concentration (rs = −0.289), total number of spermatozoa (rs = −0.255), sperm morphology (rs = −0.457), sperm progressive motility (rs = −0.524), and eosin-negative and HOS-test reactive sperm cells (rs = −0.524 and rs = −0.537, respectively) (Table 5).

4. Discussion

Generally, > 30% sperm cells with DNA damage is considered to be a cut-off point for a high risk of infertility [25,28,32,33,34,35]. However, in our study, ROC analysis of SDF to distinguish between men with normal and abnormal standard semen parameters showed that the suggested optimal threshold was 18% SDF. Moreover, using our calculated cut-off point (18% SDF), significant differences in the age of men and a significant decrease in semen quality were noted. In addition, the prevalence of abnormal standard semen parameters was higher in men with SDF > 18%, and these men had a five-fold higher OR for abnormal conventional semen parameters. Furthermore, Spearman correlation coefficient rank analysis showed significant associations between conventional semen parameters and sperm DNA damage.
It should be emphasized that our obtained findings could have clinical utility. The suggested threshold of 18% SDF was lower than the reference value given by the Halosperm G2 kit manufacturer (30% SDF). Based on our findings, it seems that 30% SDF may be unsatisfactory for discriminating men with normal fertility from those with reduced fertility potential. This suggestion is partly consistent with the studies of other authors [25,34,36,37,38,39,40]. Bungum et al. [25] showed that in the range of 0–20% sperm DNA fragmentation, the chance of a spontaneous pregnancy was constant. Moreover, Majzoub et al. [36] reported that the mean of SDF for fertile subjects was 15.68 ± 0.92% (vs. infertile 27.60 ± 1.02%). In turn, Wiweko and Utami [37] demonstrated that fertile men had 19.9% SDF (vs. infertile 29.9% SDF). Additionally, other researchers [34,38,39,40] considered that 0–15% SDF is related to a high fertility potential, while 16–30% and >30% correlated with moderate and low fertility potentials, respectively.
Our second ROC evaluation revealed the predictive value of age and standard semen parameters for distinguishing between men with > 18% SDF and ≤ 18% SDF. Importantly, the cut-off points were as follows: sperm concentration 13.80 mln/mL, total sperm count 27.50 mln, and sperm morphology 2%. Our findings suggest that with the above values, which are slightly lower than the reference range given by WHO [29], we can expect better quality sperm DNA. On the other hand, the cut-off point for progressive motility was 50.00%, eosin-positive sperm cells was 74.00%, and HOS test-positive sperm cells was 71.00%. This means that we can expect better quality sperm DNA when values of sperm progressive motility and vitality are significantly higher than the WHO criteria. In turn, only the cut-off point for TZI (1.52) was in accordance with data reported by Menkveld et al. [41], in which an increase above this value may result in a decrease in sperm DNA quality. This result concerning the predictive value of male age for sperm DNA damage was unexpected. The study suggested that an age above 32 years can correlate with the deterioration of the quality of sperm chromatin. This result is particularly interesting, because most authors show that a decline in sperm DNA quality usually occurs after the age of 40 and sometimes after 35, which is commonly classified as advanced paternal age [10,42,43,44].

5. Study Limitations

Some limitations of our study must be addressed. Firstly, the method we used to reveal SDF was the SCD, and we have to highlight that this method has some known disadvantages, such as the indirect assessment of sperm DNA and the susceptibility to subjective assessment of sperm DNA dispersion, where there is a risk of over-interpretation of the results [45,46,47]. As presented by Javed et al. [45] and Ribas-Maynou et al. [47], these methods directly assessed with double-strand DNA breaks like alkaline comet test, TUNEL, or SCSA, have grater clinical utility for distinguishing between fertile and infertile patients than SCD. On the other hand, those same authors admitted that an SCD test also has an important clinical utility [45,47]. Moreover, this method had some advantages: it is simple to perform, precise, highly reproducible, inexpensive, and advanced laboratory equipment is not required [46]. Furthermore, some authors [11,12,45,46] indicated that the complementary assessment of male fertility potential, including standard semen parameters and the SCD method, is justified and may provide clinically significant data about sperm fertilizing ability.
It is also worth mentioning that the clinically useful threshold of SDF is difficult to estimate [24,25,26,27,28,48]. In our study, the cut-off point of SDF for distinguishing between men with normal and abnormal standard semen parameters was 18%, not 30%, as previously suggested by the manufacturer of the Halo Sperm test. It is possible that if we limited the group of men to those with proven fertility and to those with isolated male fertility problems, the threshold value of SDF based on ROC analysis would be different.

6. Conclusions

In light of our findings, we can conclude that men with >18% SDF have a higher risk for abnormal standard semen parameters, while age and obtained standard semen parameters have a predictive value for SDF. Our statistical data indicate association between SDF and parameters of basic semen analysis; however, it is possible that men with normal standard semen parameters may have reduced fertility potential due to diminished sperm chromatin integrity. Therefore, DNA fragmentation testing and conventional semen analysis can be considered as complementary tools in the evaluation of male fertility potential.

Author Contributions

Conceptualization: K.G. and M.P.; Methodology: K.G., M.P.; Patients Examination: M.K. (Michał Kups) and M.L.; Samples Analysis: K.G., J.J., A.R.-G.; Data Analysis: K.G., M.P.; Writing—Original Draft Preparation, K.G.; Writing—Review & Editing, K.G., M.P.; M.K. (Maciej Kurpisz), M.F.; Visualization, K.G.; Supervision, M.P.

Funding

This work was supported by the Pomeranian Medical University in Szczecin, Szczecin, Poland. Grant no. WNoZ-322-04/S/16/2018 and grant no. FSN-322-5/2016.

Acknowledgments

We would like to thank all participants of our study.

Conflicts of Interest

All authors state that they have no conflicts of interest.

References

  1. Inhorn, M.C.; Patrizio, P. Infertility around the globe: New thinking on gender, reproductive technologies and global movements in the 21st century. Hum. Reprod. Update 2015, 21, 411–426. [Google Scholar] [CrossRef] [PubMed]
  2. Pan, M.M.; Hockenberry, M.S.; Kirby, E.W.; Lipshultz, L.I. Male Infertility Diagnosis and Treatment in the Era of In vitro Fertilization and Intracytoplasmic Sperm Injection. Med. Clin. N. Am. 2018, 102, 337–347. [Google Scholar] [CrossRef] [PubMed]
  3. Uppangala, S.; Pudakalakatti, S.; D’souza, F.; Salian, S.R.; Kalthur, G.; Kumar, P.; Atreya, H.; Adiga, S.K. Influence of sperm DNA damage on human preimplantation embryo metabolism. Reprod. Biol. 2016, 16, 234–241. [Google Scholar] [CrossRef] [PubMed]
  4. Agarwal, A.; Mulgund, A.; Hamada, A.; Chyatte, M.R. A unique view on male infertility around the globe. Reprod. Biol. Endocrinol. 2015, 13, 37. [Google Scholar] [CrossRef] [PubMed]
  5. Bonde, J.P. Male reproductive organs are at risk from environmental hazards. Asian J. Androl. 2010, 12, 152–156. [Google Scholar] [CrossRef] [PubMed]
  6. Agarwal, A.; Sharma, R.; Ahmad, G.; Sharma, R.; Ahmad, G. Sperm chromatin assessment. In Textbook of Assisted Reproductive Techniques, 5th ed.; CRC Press: Boca Raton, FL, USA, 2017; pp. 65–87. [Google Scholar]
  7. Kazerooni, T.; Asadi, N.; Jadid, L.; Kazerooni, M.; Ghanadi, A.; Ghaffarpasand, F.; Kazerooni, Y.; Zolghadr, J. Evaluation of sperm’s chromatin quality with acridine orange test, chromomycin A3 and aniline blue staining in couples with unexplained recurrent abortion. J. Assist. Reprod. Genet. 2009, 26, 591–596. [Google Scholar] [CrossRef] [PubMed]
  8. Rex, A.S.; Aagaard, J.; Fedder, J. DNA fragmentation in spermatozoa: A historical review. Andrology 2017, 5, 622–630. [Google Scholar] [CrossRef]
  9. Sharma, R.; Agarwal, A.; Rohra, V.K.; Assidi, M.; Abu-Elmagd, M.; Turki, R.F. Effects of increased paternal age on sperm quality, reproductive outcome and associated epigenetic risks to offspring. Reprod. Biol. Endocrinol. 2015, 13, 35. [Google Scholar] [CrossRef]
  10. Yatsenko, A.N.; Turek, P.J. Reproductive genetics and the aging male. J. Assist. Reprod. Genet. 2018, 35, 933–941. [Google Scholar] [CrossRef]
  11. Evgeni, E.; Lymberopoulos, G.; Touloupidis, S.; Asimakopoulos, B. Sperm nuclear DNA fragmentation and its association with semen quality in Greek men. Andrologia 2015, 47, 1166–1174. [Google Scholar] [CrossRef]
  12. Evgeni, E.; Lymberopoulos, G.; Gazouli, M.; Asimakopoulos, B. Conventional semen parameters and DNA fragmentation in relation to fertility status in a Greek population. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015, 18, 17–23. [Google Scholar] [CrossRef] [PubMed]
  13. Agarwal, A.; Panner Selvam, M.K.; Baskaran, S.; Cho, C.-L. Sperm DNA damage and its impact on male reproductive health: A critical review for clinicians, reproductive professionals and researchers. Expert Rev. Mol. Diagn. 2019. [Google Scholar] [CrossRef] [PubMed]
  14. Gill, K.; Rosiak, A.; Gaczarzewicz, D.; Jakubik, J.; Kurzawa, R.; Kazienko, A.; Rymaszewska, A.; Laszczynska, M.; Grochans, E.; Piasecka, M. The effect of human sperm chromatin maturity on ICSI outcomes. Hum. Cell 2018, 31, 220–231. [Google Scholar] [CrossRef] [PubMed]
  15. Bach, P.V.; Schlegel, P.N. Sperm DNA damage and its role in IVF and ICSI. Basic Clin. Androl. 2016, 26, 15. [Google Scholar] [CrossRef]
  16. Shamsi, M.B.; Imam, S.N.; Dada, R. Sperm DNA integrity assays: Diagnostic and prognostic challenges and implications in management of infertility. J. Assist. Reprod. Genet. 2011, 28, 1073–1085. [Google Scholar] [CrossRef] [PubMed]
  17. van der Horst, G.; du Plessis, S.S. Not just the marriage of figaro: But the marriage of who/eshre semen analysis criteria with sperm functionality. Adv. Androl. Online 2017, 4, 6–21. [Google Scholar]
  18. Tan, J.; Taskin, O.; Albert, A.; Bedaiwy, M.A. Association between sperm DNA fragmentation and idiopathic recurrent pregnancy loss: A systematic review and meta-analysis. Reprod. Biomed. Online 2019. [Google Scholar] [CrossRef] [PubMed]
  19. Cho, C.-L.; Agarwal, A. Role of sperm DNA fragmentation in male factor infertility: A systematic review. Arab. J. Urol. 2018, 16, 21–34. [Google Scholar] [CrossRef] [Green Version]
  20. Cho, C.-L.; Agarwal, A.; Majzoub, A.; Esteves, S.C. Clinical utility of sperm DNA fragmentation testing: Concise practice recommendations. Transl. Androl. Urol. 2017, 6, 366–373. [Google Scholar] [CrossRef]
  21. McQueen, D.B.; Zhang, J.; Robins, J.C. Sperm DNA fragmentation and recurrent pregnancy loss: A systematic review and meta-analysis. Fertil. Steril. 2019. [Google Scholar] [CrossRef]
  22. Agarwal, A.; Majzoub, A.; Esteves, S.C.; Ko, E.; Ramasamy, R.; Zini, A. Clinical utility of sperm DNA fragmentation testing: Practice recommendations based on clinical scenarios. Transl. Androl. Urol. 2016, 5, 935–950. [Google Scholar] [CrossRef] [PubMed]
  23. Jerre, E.; Bungum, M.; Evenson, D.; Giwercman, A. Sperm chromatin structure assay high DNA stainability sperm as a marker of early miscarriage after intracytoplasmic sperm injection. Fertil. Steril. 2019. [CrossRef] [PubMed]
  24. Bungum, M.; Humaidan, P.; Axmon, A.; Spano, M.; Bungum, L.; Erenpreiss, J.; Giwercman, A. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum. Reprod. 2007, 22, 174–179. [Google Scholar] [CrossRef] [PubMed]
  25. Bungum, M.; Bungum, L.; Giwercman, A. Sperm chromatin structure assay (SCSA): A tool in diagnosis and treatment of infertility. Asian J. Androl. 2011, 13, 69–75. [Google Scholar] [CrossRef] [PubMed]
  26. Erenpreiss, J.; Elzanaty, S.; Giwercman, A. Sperm DNA damage in men from infertile couples. Asian J. Androl. 2008, 10, 786–790. [Google Scholar] [CrossRef] [PubMed]
  27. Giwercman, A.; Lindstedt, L.; Larsson, M.; Bungum, M.; Spano, M.; Levine, R.J.; Rylander, L. Sperm chromatin structure assay as an independent predictor of fertility in vivo: A case-control study. Int. J. Androl. 2010, 33, e221–e227. [Google Scholar] [CrossRef]
  28. Evenson, D.P. Evaluation of sperm chromatin structure and DNA strand breaks is an important part of clinical male fertility assessment. Transl. Androl. Urol. 2017, 6, 495–500. [Google Scholar] [CrossRef] [PubMed]
  29. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 5th ed.; World Health Organization Press: Geneva, Switzerland, 2010. [Google Scholar]
  30. Wdowiak, A.; Wdowiak, A.; Bakalczuk, S. Relationship between alcohol consumption and sperm nuclear dna fragmentation and pregnancy. Postep Androl. Online 2016, 3, 14–21. [Google Scholar]
  31. Gill, K.; Jakubik, J.; Kups, M.; Rosiak-Gill, A.; Kurzawa, R.; Kurpisz, M.; Fraczek, M.; Piasecka, M. The impact of sedentary work on sperm nuclear DNA integrity. Folia Histochem. Cytobiol. 2019, 57, 15–22. [Google Scholar] [CrossRef]
  32. Bounartzi, T.; Dafopoulos, K.; Anifandis, G.; Messini, C.I.; Koutsonikou, C.; Kouris, S.; Satra, M.; Sotiriou, S.; Vamvakopoulos, N.; Messinis, I.E. Pregnancy prediction by free sperm DNA and sperm DNA fragmentation in semen specimens of IVF/ICSI-ET patients. Hum. Fertil. 2016, 19, 56–62. [Google Scholar] [CrossRef]
  33. Cissen, M.; van Wely, M.; Scholten, I.; Mansell, S.; de Bruin, J.P.; Mol, B.W.; Braat, D.; Repping, S.; Hamer, G. Measuring Sperm DNA Fragmentation and Clinical Outcomes of Medically Assisted Reproduction: A Systematic Review and Meta-Analysis. PLoS ONE 2016, 11, e0165125. [Google Scholar] [CrossRef] [PubMed]
  34. Evenson, D.P.; Larson, K.L.; Jost, L.K. Sperm chromatin structure assay: Its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. J. Androl. 2002, 23, 25–43. [Google Scholar] [CrossRef] [PubMed]
  35. Simon, L.; Emery, B.R.; Carrell, D.T. Review: Diagnosis and impact of sperm DNA alterations in assisted reproduction. Best Pract. Res. Clin. Obstet. Gynaecol. 2017, 44, 38–56. [Google Scholar] [CrossRef] [PubMed]
  36. Majzoub, A.; Arafa, M.; Mahdi, M.; Agarwal, A.; Al Said, S.; Al-Emadi, I.; Alattar, A.; Al Rumaihi, K.; Elbardisi, H. Oxidation-reduction potential and sperm DNA fragmentation, and their associations with sperm morphological anomalies amongst fertile and infertile men. Arab. J. Urol. 2018, 16, 87–95. [Google Scholar] [CrossRef] [PubMed]
  37. Wiweko, B.; Utami, P. Predictive value of sperm deoxyribonucleic acid (DNA) fragmentation index in male infertility. Basic Clin. Androl. 2017, 27, 1. [Google Scholar] [CrossRef]
  38. Leach, M.; Aitken, R.J.; Sacks, G. Sperm DNA fragmentation abnormalities in men from couples with a history of recurrent miscarriage. Aust. N. Z. J. Obstet. Gynaecol. 2015, 55, 379–383. [Google Scholar] [CrossRef]
  39. Abdelbaki, S.A.; Sabry, J.H.; Al-Adl, A.M.; Sabry, H.H. The impact of coexisting sperm DNA fragmentation and seminal oxidative stress on the outcome of varicocelectomy in infertile patients: A prospective controlled study. Arab. J. Urol. 2017, 15, 131–139. [Google Scholar] [CrossRef] [Green Version]
  40. Al Omrani, B.; Al Eisa, N.; Javed, M.; Al Ghedan, M.; Al Matrafi, H.; Al Sufyan, H. Associations of sperm DNA fragmentation with lifestyle factors and semen parameters of Saudi men and its impact on ICSI outcome. Reprod. Biol. Endocrinol. 2018, 16, 49. [Google Scholar] [CrossRef]
  41. Menkveld, R.; Wong, W.Y.; Lombard, C.J.; Wetzels, A.M.M.; Thomas, C.M.G.; Merkus, H.M.W.M.; Steegers-Theunissen, R.P.M. Semen parameters, including WHO and strict criteria morphology, in a fertile and subfertile population: An effort towards standardization of in-vivo thresholds. Hum. Reprod. 2001, 16, 1165–1171. [Google Scholar] [CrossRef]
  42. Kaarouch, I.; Bouamoud, N.; Madkour, A.; Louanjli, N.; Saadani, B.; Assou, S.; Aboulmaouahib, S.; Amzazi, S.; Copin, M.; Benkhalifa, M. Paternal age: Negative impact on sperm genome decays and IVF outcomes after 40 years. Mol. Reprod. Dev. 2018, 85, 271–280. [Google Scholar] [CrossRef]
  43. Petersen, C.G.; Mauri, A.L.; Vagnini, L.D.; Renzi, A.; Petersen, B.; Mattila, M.; Comar, V.; Ricci, J.; Dieamant, F.; Oliveira, J.B.A.; et al. The effects of male age on sperm DNA damage: An evaluation of 2,178 semen samples. JBRA Assist. Reprod. 2018, 22, 323–330. [Google Scholar] [CrossRef] [PubMed]
  44. Rosiak, A.; Gill, K.; Jakubik, J.; Kupś, M.; Patorski, Ł.; Kurzawa, R.; Piasecka, M. [Czy zaawansowany wiek ojcowski ma wpływ na sukces rozrodczy? Część I: Ocena wybranych parametrów seminologicznych] Is advanced paternal age a reproductive risk? Part I: Assessment of selected standard sperm characteristics. Postep Androl. Online 2017, 4, 23–32. [Google Scholar]
  45. Javed, A.; Talkad, M.S.; Ramaiah, M.K. Evaluation of sperm DNA fragmentation using multiple methods: A comparison of their predictive power for male infertility. Clin. Exp. Reprod. Med. 2019, 46, 14–21. [Google Scholar] [CrossRef] [PubMed]
  46. Evgeni, E.; Charalabopoulos, K.; Asimakopoulos, B. Human sperm DNA fragmentation and its correlation with conventional semen parameters. J. Reprod. Infertil. 2014, 15, 2–14. [Google Scholar]
  47. Ribas-Maynou, J.; García-Peiró, A.; Fernández-Encinas, A.; Abad, C.; Amengual, M.J.; Prada, E.; Navarro, J.; Benet, J. Comprehensive analysis of sperm DNA fragmentation by five different assays: TUNEL assay, SCSA, SCD test and alkaline and neutral Comet assay. Andrology 2013, 1, 715–722. [Google Scholar] [CrossRef] [PubMed]
  48. Anifandis, G.; Bounartzi, T.; Messini, C.I.; Dafopoulos, K.; Markandona, R.; Sotiriou, S.; Tzavella, A.; Messinis, I.E. Sperm DNA fragmentation measured by Halosperm does not impact on embryo quality and ongoing pregnancy rates in IVF/ICSI treatments. Andrologia 2015, 47, 295–302. [Google Scholar] [CrossRef] [PubMed]
Ijerph 16 02004 g001 550
Figure 1. ROC curve analysis for SDF. Criterion variables are normal and abnormal standard semen parameters. AUC—area under the curve; ROC—receiver operating characteristic; SDF—sperm DNA fragmentation; p ≤ 0.05—statistical significance between obtained AUC vs. AUC = 0.5; CI 95%—95% confidence interval. The level of AUC was as follows: >0.7–0.8—satisfactory predictive value.
Figure 1. ROC curve analysis for SDF. Criterion variables are normal and abnormal standard semen parameters. AUC—area under the curve; ROC—receiver operating characteristic; SDF—sperm DNA fragmentation; p ≤ 0.05—statistical significance between obtained AUC vs. AUC = 0.5; CI 95%—95% confidence interval. The level of AUC was as follows: >0.7–0.8—satisfactory predictive value.
Ijerph 16 02004 g001
Ijerph 16 02004 g002 550
Figure 2. Scheme illustrating strategy developed in study analyses. ROC—receiver operating characteristic; SDF—sperm DNA fragmentation; OR—odds ratio; TZI—teratozoospermia index. Insert—visualization of sperm chromatin dispersion measured by Halo Sperm test. Spermatozoa with a big halo were considered as cells without SDF (green arrows), while those with a small halo were considered as cells with SDF (red arrow) (details in text).
Figure 2. Scheme illustrating strategy developed in study analyses. ROC—receiver operating characteristic; SDF—sperm DNA fragmentation; OR—odds ratio; TZI—teratozoospermia index. Insert—visualization of sperm chromatin dispersion measured by Halo Sperm test. Spermatozoa with a big halo were considered as cells without SDF (green arrows), while those with a small halo were considered as cells with SDF (red arrow) (details in text).
Ijerph 16 02004 g002
Table
Table 1. Descriptive statistics and comparison of age and standard semen parameters in men with >18% SDF and men with ≤18% SDF.
Table 1. Descriptive statistics and comparison of age and standard semen parameters in men with >18% SDF and men with ≤18% SDF.
ParametersTotalMen with >18% SDFMen with ≤18% SDF
nnn
Median (Range)Median (Range)Median (Range)
Mean ± SDMean ± SDMean ± SD
Age (y)n = 667n = 334n = 343
32.00 (19.00–54.00)33.00 (21.00–54.00) **31.00 (19.00–49.00)
32.20 ± 5.8033.23 ± 5.7631.19 ± 5.66
Semen volume (mL)n = 677n = 334n = 434
3.00 (0.50–11.50)3.25 (0.50–11.50)3.00 (0.50–10.00)
3.59 ± 1.693.64 ± 1.813.54 ± 1.57
Sperm concentration (×106/mL)n = 677n = 334n = 343
19.92 (0.05–283.00)14.60 (0.05–166.00) **25.70 (0.25–283.00)
28.04 ± 30.3722.44 ± 25.2133.49 ± 33.83
Total number of spermatozoa (×106)n = 677n = 334n = 343
66.00 (0.25–672.00)53.32 (0.25–672.00) **75.62 (0.50–660.25)
92.90 ± 95.4575.48 ± 83.86109.87 ± 102.83
Morphologically normal spermatozoa (%)n = 677n = 334n = 343
2.00 (0.00–15.00)1.00 (0.00–13.00) **4.00 (0.00–15.00)
3.10 ± 3.071.86 ± 2.474.31 ± 3.12
TZIn = 677n = 334n = 343
1.55 (1.13–2.58)1.63 (1.20–2.58) **1.50 (1.13–2.46)
1.60 ± 0.221.67 ± 0.241.62 ± 0.19
Sperm progressive motility (%)n = 677n = 334n = 343
51.00 (0.00–89.00)39.00 (0.00–85.00) **61.00 (2.00–89.00)
47.68 ± 21.9838.16 ± 21.3956.94 ± 18.31
Eosin-negative spermatozoa—live cells (%)n = 677n = 334n = 343
77.00 (0.00–96.00)70.50 (0.00–94.00) **81.00 (14.00–96.00)
72.73 ± 17.0265.80 ± 19.1179.48 ± 11.17
HOS test-positive spermatozoa—live cells (%)n = 615n = 288n = 327
76.00 (0.00–94.00)70.00 (0.00–91.00) **80.00 (12.00–94.00)
71.76 ± 16.9764.77 ± 19.0577.91 ± 11.91
Peroxidase-positive cells (mln/mL)n = 677n = 334n = 343
0.20 (0.00–27.00)0.25 (0.00–10.25) *0.12 (0.00–27.00)
0.49 ± 1.450.53 ± 1.210.24 ± 0.00
HOS test—hypo-osmotic swelling test; n—number of subjects; SD—standard deviation; SDF—sperm DNA fragmentation; TZI—teratozoospermia index. * Significant differences between men with ≤18% SDF at p < 0.010; ** Significant differences between men with ≤18% SDF at p < 0.001, Mann–Whitney U test.
Table
Table 2. Prevalence of normal and abnormal standard semen parameters in men with >18% SDF and ≤18% SDF.
Table 2. Prevalence of normal and abnormal standard semen parameters in men with >18% SDF and ≤18% SDF.
GroupStandard Semen Parameters
Normal
N (%)		Abnormal &
N (%)
Men with > 18% SDF (n = 334)59 (17.66) **275 (82.34) **
Men with ≤ 18% SDF (n = 343)184 (53.64)159 (46.36)
& At least one abnormal standard semen parameter according to the WHO [29] (details in Subject section). n—number of subjects. ** Significant differences between men with ≤18% SDF at p < 0.001, chi2 test. SDF—sperm DNA fragmentation.
Table
Table 3. Odds ratio (OR) for abnormal standard semen parameters in men with >18% SDF (n = 334) compared to men with ≤18% SDF (n = 343).
Table 3. Odds ratio (OR) for abnormal standard semen parameters in men with >18% SDF (n = 334) compared to men with ≤18% SDF (n = 343).
Semen CategoryMen with >18% SDF
N (%)		Men with ≤18% SDF
N (%)		OR (95%CI)
Abnormal standard semen parameters &275 (82.34)159 (46.36)5.394 (3.7922–7.6720) **
& At least one abnormal standard semen parameter WHO [29] (details in Subject section). n—number of subjects. ** Statistical significance at p < 0.001; 95% CI—95% confidence interval. SDF—sperm DNA fragmentation.
Table
Table 4. ROC curve analysis for age and standard semen parameters. Criterion variable is SDF level >18%.
Table 4. ROC curve analysis for age and standard semen parameters. Criterion variable is SDF level >18%.
ParameterAUCSECI 95%Suggested Optimal Cut-Off Point
Age (y)0.601 **0.0210.563–0.63832.00
Semen volume (mL)0.5060.0220.468–0.5456.00
Sperm concentration (×106/mL)0.641 **0.0210.603–0.67713.80
Total number of spermatozoa (×106)0.625 **0.0210.587–0.66127.75
Morphologically normal spermatozoa (%)0.740 **0.0180.705–0.7722.00
TZI0.677 **0.0200.641–0.7131.52
Sperm progressive motility (%)0.746 **0.0180.711–0.77850.00
Eosine-negative spermatozoa—live cells (%)0.743 **0.0180.708–0.77574.00
HOS test-positive spermatozoa—live cells (%)0.743 **0.0190.706–0.77771.00
Peroxidase-positive cells (mln/mL)0.5670.0210.529–0.6050.00
AUC—area under the curve; ** Statistical significance with AUC = 0.5 at p < 0.001; CI 95%—95% confidence interval; HOS test—hypo-osmotic swelling test; ROC—receiver operating characteristic; SDF—sperm DNA fragmentation; TZ—teratozoospermia index. The levels of AUC were as follows: 0.9–1.0—excellent predictive value; >0.8–0.9—good predictive value; >0.7–0.8—satisfactory predictive value; >0.6–0.7—moderate predictive value; and 0.5–0.6—insufficient predictive value.
Table
Table 5. Rank Spearman correlations (rs) between human sperm chromatin fragmentation (SDF), male age and standard semen parameters (n = 676).
Table 5. Rank Spearman correlations (rs) between human sperm chromatin fragmentation (SDF), male age and standard semen parameters (n = 676).
Parametersrs
Age (y)0.211 p < 0.001
Semen volume (mL)−0.010 p = 0.794
Sperm concentration (×106/mL)−0.289 p < 0.001
Total number of spermatozoa (×106)−0.255 p < 0.001
Morphologically normal spermatozoa (%)−0.457 p < 0.001
TZI0.339 p < 0.001
Sperm progressive motility (%)−0.524 p < 0.001
Eosin-negative spermatozoa—live cells (%)−0.524 p < 0.001
HOS test-positive spermatozoa—live cells (%)−0.537 p < 0.001
Peroxidase-positive cells (mln/mL)0.125 p = 0.001
The interpretation of rs value: < 0.2 lack of linear dependence; 0.2–0.4—weak dependence; >0.4–0.7—moderate dependence; >0.7–0.9—strong dependence; and > 0.9—very strong dependence. n—number of subjects, statistical significance at p < 0.05; HOS test—hypo-osmotic swelling test, TZI—teratozoospermia index.

Share and Cite

MDPI and ACS Style

Gill, K.; Jakubik, J.; Rosiak-Gill, A.; Kups, M.; Lukaszuk, M.; Kurpisz, M.; Fraczek, M.; Piasecka, M. Utility and Predictive Value of Human Standard Semen Parameters and Sperm DNA Dispersion for Fertility Potential. Int. J. Environ. Res. Public Health 2019, 16, 2004. https://doi.org/10.3390/ijerph16112004

AMA Style

Gill K, Jakubik J, Rosiak-Gill A, Kups M, Lukaszuk M, Kurpisz M, Fraczek M, Piasecka M. Utility and Predictive Value of Human Standard Semen Parameters and Sperm DNA Dispersion for Fertility Potential. International Journal of Environmental Research and Public Health. 2019; 16(11):2004. https://doi.org/10.3390/ijerph16112004

Chicago/Turabian Style

Gill, Kamil, Joanna Jakubik, Aleksandra Rosiak-Gill, Michał Kups, Mariusz Lukaszuk, Maciej Kurpisz, Monika Fraczek, and Małgorzata Piasecka. 2019. "Utility and Predictive Value of Human Standard Semen Parameters and Sperm DNA Dispersion for Fertility Potential" International Journal of Environmental Research and Public Health 16, no. 11: 2004. https://doi.org/10.3390/ijerph16112004

APA Style

Gill, K., Jakubik, J., Rosiak-Gill, A., Kups, M., Lukaszuk, M., Kurpisz, M., Fraczek, M., & Piasecka, M. (2019). Utility and Predictive Value of Human Standard Semen Parameters and Sperm DNA Dispersion for Fertility Potential. International Journal of Environmental Research and Public Health, 16(11), 2004. https://doi.org/10.3390/ijerph16112004

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop